Leidos, Inc.
USPTO PatentsView assignee record - 117 granted patents across 76 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Leidos ranks #3,203 of 49,997 tracked US assignees by granted-patent volume, with 117 patents across 76 technology areas.
- #3,203
- of 49,997 US assignees by volume
- Top 8%
- by Innovation Score (53.8/100)
- 15.2
- avg claims per patent
- -56%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3203 · US Corporation #3,203 · 117 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 117 grants
- TOP-DECILE #3,203/49,997
- PHOTO-FINISH John Mezzalingua…
- CPC-WIDE C07K · 76 areas
- INNOV-PAR 53.8/100
- CLAIMS-RICH 15.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -56% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: John Mezzalingua Associates, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Leidos’s 53.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Leidos
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Desktop Metal · near
Desktop Metal · near
54 score
- Federal-Mogul… · near
Federal-Mogul… · near
54 score
- Leidos · this assignee
Leidos · this assignee
54 score
- University of… · near
University of… · near
54 score
- Xyleco · near
Xyleco · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Leidos's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Leidos?
Each dot is one of Leidos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Leidos’s own 15.2 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
How Leidos's grant cadence moved
Between 2020–2024, Leidos, Inc. received 34 grants versus 77 in 2015–2019 (-56% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 20 grants and bottomed in 2021 at 5. Lead class C07K accounts for 18.8% of the portfolio across 76 subclasses. Volume neighbours: John Mezzalingua Associates, LLC (#3,199) and PlayNitride Inc. (#3,207).
Leidos's three-year grant acceleration
From 2019–2021 to 2022–2024, Leidos, Inc. moved from 33 to 16 grants (0.48x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,728. See the growth leaderboard.
Who files at Leidos's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- John Mezzalingua…
John Mezzalingua Associates, LLC
117 patents
- Kansai Paint
Kansai Paint Co., Ltd.
117 patents
- Karlsruher Instit…
Karlsruher Institut FÜR Technologie
117 patents
- Krohne Messtechnik
Krohne Messtechnik GmbH
117 patents
- Merry (Shenzhen)
Merry Electronics(Shenzhen) Co., Ltd.
117 patents
- Modine Manufactur…
Modine Manufacturing Company
117 patents
- Nasdaq Technology…
Nasdaq Technology AB
117 patents
- Playnitride
PlayNitride Inc.
117 patents
- Leidos ◀
Leidos, Inc.
117 patents
What this shows Leidos holds 117 patents at rank #3,203, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Leidos
By rank, the assignees closest to #3,203 in granted patent volume.
- John Mezzalingua Associates, LLC #3,199 · 117 patents
- Kansai Paint Co., Ltd. #3,200 · 117 patents
- Karlsruher Institut FÜR Technologie #3,201 · 117 patents
- Krohne Messtechnik GmbH #3,202 · 117 patents
- Merry Electronics(Shenzhen) Co., Ltd. #3,204 · 117 patents
- Modine Manufacturing Company #3,205 · 117 patents
- Nasdaq Technology AB #3,206 · 117 patents
- PlayNitride Inc. #3,207 · 117 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Leidos's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Leidos, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Leidos ranks #442 of 3,615 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Similar claim depth
Nearest assignees by average claims per patent (15.2 here).
Leidos's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 13 | 11.1% |
| 2016 | 20 | 17.1% |
| 2017 | 10 | 8.5% |
| 2018 | 19 | 16.2% |
| 2019 | 15 | 12.8% |
| 2020 | 13 | 11.1% |
| 2021 | 5 | 4.3% |
| 2022 | 5 | 4.3% |
| 2023 | 6 | 5.1% |
| 2024 | 5 | 4.3% |
| 2025partial year | 6 | 5.1% |
Which technologies does Leidos, Inc. patent most?
Top 15 of 76 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Leidos, Inc.'s patent record in context - here's where to go next.
- Leidos, Inc.'s lead technology class is C07K (Peptides), 18.8% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #3,203 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Leidos, Inc. against John Mezzalingua Associates, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.